NCT07124416

Brief Summary

This study aims to conduct a cross-sectional study to compare the differences in clinical indices, patient-reported outcomes, and levels of inflammatory factors in peri-implant gingival crevicular fluid between sites with adequate (≥ 2 mm) and inadequate (\< 2 mm) keratinized mucosa after implant restoration, in order to explore the impact of the presence of keratinized mucosa on peri-implant soft and hard tissue health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Jul 2025Dec 2026

Study Start

First participant enrolled

July 10, 2025

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

July 20, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 15, 2025

Status Verified

August 1, 2025

Enrollment Period

1.4 years

First QC Date

July 20, 2025

Last Update Submit

August 8, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Width of Keratinized Mucosa, KMW

    on the day of enrollment

  • Plaque Index(PI)

    on the day of enrollment

  • Bleeding on Probing(BOP)

    on the day of enrollment

  • Peri-implant Probing Depth(PPD)

    on the day of enrollment

  • Marginal Bone Loss(MBL)

    The X-ray examination will be completed on the day of enrollment

  • Patient Satisfaction

    visual analogue scale \[VAS\] 0-10,e.g., not at all satisfied to perfectly satisfied

    on the day of enrollment

  • Immunological parameters in peri-implant crevicular fluids(PICF)

    PICF samples were collected from buccal aspects of implants after removing all supragingival plaque. The levels of IL-1β and PGE2 in PICF were measured using a sandwich ELISA kit.

    The PICF will be collected on the day of enrollment

Study Arms (2)

inadequate keratinized mucosa

peri-implant width of keratinized mucosa less than 2 mm

adequate keratinized mucosa

peri-implant width of keratinized mucosa ≥ 2 mm

Other: No intervention

Interventions

No intervention: observational case-control study

adequate keratinized mucosa

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who have completed dental implant restoration(single crown or fixed bridge restorations) for at least 6 months and undergo routine follow-up examinations.

You may qualify if:

  • Individuals aged 18 to 70 years (inclusive of 18 and 70 years), of any gender;
  • Patients who have undergone dental implant restoration是(single crown or fixed bridge restorations) at the Stomatology Hospital, Zhejiang University School of medicine and have had their final restoration for at least 6 months;
  • Patients who voluntarily participate and sign the informed consent form after being fully informed, and who cooperate with relevant examinations.

You may not qualify if:

  • Patients who are unwilling to participate in the follow-up of this study for various reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Stomatology Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310000, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2025

First Posted

August 15, 2025

Study Start

July 10, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 15, 2025

Record last verified: 2025-08

Locations